The World Health Organization (WHO) has recently unveiled its 2023 Global Tuberculosis (TB) report, showcasing positive advancements in the expansion of TB diagnosis and treatment services worldwide. This signifies a hopeful shift in countering the negative impacts of COVID-19 disruptions on TB services. Gathering data from 192 countries and regions, the report reveals that in 2022, a substantial number of individuals received TB diagnoses, marking the highest recorded figure since WHO began global TB monitoring in 1995.

This increase is credited to notable enhancements in healthcare access and provision in many countries. Particularly, regions heavily affected by the pandemic have seen significant recoveries in TB services. WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, expressed confidence in the substantial progress made, emphasizing the unique opportunity to bring the TB story to a close. On a global scale, a significant number of people were estimated to contract TB in 2022, showing an increase from the previous year. Geographically, in 2022, the majority of TB cases emerged in regions significantly impacted by the pandemic. Although TB-related deaths slightly decreased, disruptions caused by COVID-19 led to additional TB-related fatalities in recent years. Multidrug-resistant TB (MDR-TB) remains a notable public health concern, and efforts are underway to improve treatment accessibility. The report also acknowledges some progress in developing new TB diagnostics, drugs, and vaccines. However, overall investment in these areas remains a limiting factor.